144 related articles for article (PubMed ID: 15327888)
21. The geldanamycins are potent inhibitors of the hepatocyte growth factor/scatter factor-met-urokinase plasminogen activator-plasmin proteolytic network.
Webb CP; Hose CD; Koochekpour S; Jeffers M; Oskarsson M; Sausville E; Monks A; Vande Woude GF
Cancer Res; 2000 Jan; 60(2):342-9. PubMed ID: 10667586
[TBL] [Abstract][Full Text] [Related]
22. Expression of androgen and estrogen related proteins in normal weight and obese prostate cancer patients.
Gross M; Ramirez C; Luthringer D; Nepomuceno E; Vollmer R; Burchette J; Freedland SJ
Prostate; 2009 Apr; 69(5):520-7. PubMed ID: 19107851
[TBL] [Abstract][Full Text] [Related]
23. Dominant negative Met reduces tumorigenicity-metastasis and increases tubule formation in mammary cells.
Firon M; Shaharabany M; Altstock RT; Horev J; Abramovici A; Resau JH; Vande Woude GF; Tsarfaty I
Oncogene; 2000 May; 19(20):2386-97. PubMed ID: 10828880
[TBL] [Abstract][Full Text] [Related]
24. Hedgehog pathway activity in the LADY prostate tumor model.
Gipp J; Gu G; Crylen C; Kasper S; Bushman W
Mol Cancer; 2007 Mar; 6():19. PubMed ID: 17343742
[TBL] [Abstract][Full Text] [Related]
25. A stroma targeted therapy enhances castration effects in a transplantable rat prostate cancer model.
Johansson A; Jones J; Pietras K; Kilter S; Skytt A; Rudolfsson SH; Bergh A
Prostate; 2007 Nov; 67(15):1664-76. PubMed ID: 17854058
[TBL] [Abstract][Full Text] [Related]
26. The HGF/SF-induced phosphorylation of paxillin, matrix adhesion, and invasion of prostate cancer cells were suppressed by NK4, an HGF/SF variant.
Parr C; Davies G; Nakamura T; Matsumoto K; Mason MD; Jiang WG
Biochem Biophys Res Commun; 2001 Aug; 285(5):1330-7. PubMed ID: 11478803
[TBL] [Abstract][Full Text] [Related]
27. Anti-c-MET Nanobody - a new potential drug in multiple myeloma treatment.
Slørdahl TS; Denayer T; Moen SH; Standal T; Børset M; Ververken C; Rø TB
Eur J Haematol; 2013 Nov; 91(5):399-410. PubMed ID: 23952536
[TBL] [Abstract][Full Text] [Related]
28. Expression of the met/hepatocyte growth factor/scatter factor receptor and its ligand during differentiation of murine P19 embryonal carcinoma cells.
Yang XM; Park M
Dev Biol; 1993 Jun; 157(2):308-20. PubMed ID: 8388815
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical expression of hepatocyte growth factor and c-Met/HGF receptor in benign and malignant human prostate tissue.
Nakashiro K; Hayashi Y; Oyasu R
Oncol Rep; 2003; 10(5):1149-53. PubMed ID: 12883672
[TBL] [Abstract][Full Text] [Related]
30. Resveratrol Suppresses Prostate Cancer Epithelial Cell Scatter/Invasion by Targeting Inhibition of Hepatocyte Growth Factor (HGF) Secretion by Prostate Stromal Cells and Upregulation of E-cadherin by Prostate Cancer Epithelial Cells.
Hsieh TC; Wu JM
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32143478
[TBL] [Abstract][Full Text] [Related]
31. Met and hepatocyte growth factor/scatter factor signal transduction in normal melanocytes and melanoma cells.
Halaban R; Rubin JS; Funasaka Y; Cobb M; Boulton T; Faletto D; Rosen E; Chan A; Yoko K; White W
Oncogene; 1992 Nov; 7(11):2195-206. PubMed ID: 1331934
[TBL] [Abstract][Full Text] [Related]
32. Expression of the hepatocyte growth factor/scatter factor receptor tyrosine kinase is localized to epithelia in the adult mouse.
Yang XM; Park M
Lab Invest; 1995 Oct; 73(4):483-91. PubMed ID: 7474919
[TBL] [Abstract][Full Text] [Related]
33. Chronic exposure to fulvestrant promotes overexpression of the c-Met receptor in breast cancer cells: implications for tumour-stroma interactions.
Hiscox S; Jordan NJ; Jiang W; Harper M; McClelland R; Smith C; Nicholson RI
Endocr Relat Cancer; 2006 Dec; 13(4):1085-99. PubMed ID: 17158755
[TBL] [Abstract][Full Text] [Related]
34. Hepatocyte growth factor (HGF), keratinocyte growth factor (KGF), and their receptors in human breast cells and tissues: alternative receptors.
Wilson SE; Weng J; Chwang EL; Gollahon L; Leitch AM; Shay JW
Cell Mol Biol Res; 1994; 40(4):337-50. PubMed ID: 7866434
[TBL] [Abstract][Full Text] [Related]
35. Identification of a hepatocyte growth factor autocrine loop in a murine mammary carcinoma.
Rahimi N; Tremblay E; McAdam L; Park M; Schwall R; Elliott B
Cell Growth Differ; 1996 Feb; 7(2):263-70. PubMed ID: 8822210
[TBL] [Abstract][Full Text] [Related]
36. Androgen deprivation induces human prostate epithelial neuroendocrine differentiation of androgen-sensitive LNCaP cells.
Yuan TC; Veeramani S; Lin FF; Kondrikou D; Zelivianski S; Igawa T; Karan D; Batra SK; Lin MF
Endocr Relat Cancer; 2006 Mar; 13(1):151-67. PubMed ID: 16601285
[TBL] [Abstract][Full Text] [Related]
37. Met-HGF/SF signal transduction induces mimp, a novel mitochondrial carrier homologue, which leads to mitochondrial depolarization.
Yerushalmi GM; Leibowitz-Amit R; Shaharabany M; Tsarfaty I
Neoplasia; 2002; 4(6):510-22. PubMed ID: 12407445
[TBL] [Abstract][Full Text] [Related]
38. c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention.
Christensen JG; Burrows J; Salgia R
Cancer Lett; 2005 Jul; 225(1):1-26. PubMed ID: 15922853
[TBL] [Abstract][Full Text] [Related]
39. Expression of the met-receptor and its ligand, HGF-SF during mouse embryogenesis.
Sonnenberg E; Weidner KM; Birchmeier C
EXS; 1993; 65():381-94. PubMed ID: 8380744
[TBL] [Abstract][Full Text] [Related]
40. Autocrine hepatocyte growth factor/scatter factor-Met signaling induces transformation and the invasive/metastastic phenotype in C127 cells.
Jeffers M; Rong S; Anver M; Vande Woude GF
Oncogene; 1996 Aug; 13(4):853-6. PubMed ID: 8761307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]